govt.fyi
Back to H.R. 826
US Congress· H.R. 826Passed the House

COVID Fraud Transparency Act of 2026, the official text

Shown verbatim as published by GovInfo, version rfs (Referred in Senate), captured 2026-07-23. Page markers and notes are part of the official record; nothing is edited or removed. This version at GovInfo.
119 HR 826 : COVID Fraud Transparency Act of 2026
U.S. House of Representatives
2026-06-24
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
IIB 119th CONGRESS 2d Session H. R. 826 IN THE SENATE OF THE UNITED STATES June 24, 2026 Received; read twice and referred to the Committee on Small Business and Entrepreneurship
AN ACT To require the Inspector General of the Small Business Administration to submit a quarterly report on fraud relating to certain COVID–19 loans. 1. Short title
This Act may be cited as the COVID Fraud Transparency Act of 2026 .
2. Report on fraud relating to certain COVID–19 loans
(a) In general
Not later than 60 days after the date of the enactment of this Act, and every 3 months thereafter, the Inspector General of the Small Business Administration shall submit to the Committee on Small Business of the House of Representatives and the Committee on Small Business and Entrepreneurship of the Senate a report on the number of borrowers engaged in fraud with respect to a covered loan.
(b) Elements
The report required under subsection (a) shall include, with respect to the period covered by such report—
(1) the number and total dollar amount of all covered loans made;
(2) the number of new cases of fraud and suspected fraud;
(3) the number of fraud cases resolved; and
(4) the types of fraud cases described in paragraphs (2) and (3).
(c) Covered loan defined
In this section, the term covered loan means—
(1) a loan made under paragraph (36) or (37) of section 7(a) of the Small Business Act ( 15 U.S.C. 636(a) ); or
(2) a loan made under section 7(b) of such Act ( 15 U.S.C. 636(b) ) in response to COVID–19 during the covered period (as defined in section 1110(a) of the CARES Act ( 15 U.S.C. 9009 )).
(d) Termination
This Act and the requirements of this Act shall terminate on the date that is two years after the date of the enactment of this Act.
3. Compliance with CUTGO
No such funds are authorized to be appropriated to carry out this Act.
Passed the House of Representatives June 23, 2026. Kevin F. McCumber, Clerk.
Every fact on this page links to its source, starting with the official bill record.